APA (7th ed.) Citation

Verdecchia, P., & Brückmann, M. (2018). Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation: The Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. Europace, 20(2), . https://doi.org/10.1093/europace/eux022

Chicago Style (17th ed.) Citation

Verdecchia, Paolo, and Martina Brückmann. "Dabigatran Vs. Warfarin in Relation to the Presence of Left Ventricular Hypertrophy in Patients with Atrial Fibrillation: The Randomized Evaluation of Long-term Anticoagulation TherapY (RE-LY) Study." Europace 20, no. 2 (2018). https://doi.org/10.1093/europace/eux022.

MLA (9th ed.) Citation

Verdecchia, Paolo, and Martina Brückmann. "Dabigatran Vs. Warfarin in Relation to the Presence of Left Ventricular Hypertrophy in Patients with Atrial Fibrillation: The Randomized Evaluation of Long-term Anticoagulation TherapY (RE-LY) Study." Europace, vol. 20, no. 2, 2018, https://doi.org/10.1093/europace/eux022.